Patient Outcomes May Improve With Tailored Treatment Guided by Tissue Plus Liquid Biopsies vs. Individually
Treatment guided by both tests led to better outcomes than standard of care CHICAGO – Patients with advanced solid...
Treatment guided by both tests led to better outcomes than standard of care CHICAGO – Patients with advanced solid...
CHICAGO – From 2010 to 2020, breast cancer deaths among women ages 20-49 declined significantly across all breast cancer...
Study establishes a reference for normal hematopoietic cell differentiation and identifies novel acute myeloid leukemia cell states with potential...
Lillian L. Siu, MD, FAACR, begins term as AACR President CHICAGO – The members of the American Association for...
CHICAGO – Zongertinib, a human epidermal growth factor receptor 2 (HER2)-targeted tyrosine kinase inhibitor, elicited durable responses in patients...
CHICAGO – An ultrasensitive circulating tumor DNA (ctDNA)-based liquid biopsy assay detected signs of recurrence prior to imaging and...
CHICAGO – An artificial intelligence (AI)-based model accurately classified pediatric sarcomas using digital pathology images alone, according to results...
CHICAGO – Patients with colorectal cancer who had acneiform rash and applied LUT014 gel, an investigational topical BRAF inhibitor,...
CHICAGO – A multimodal, artificial intelligence (AI)-driven model that analyzes routinely collected imaging and clinical information led to more...
CHICAGO – Artificial intelligence models, pretrained on vast datasets, significantly outperformed a standard baseline model in identifying nonmelanoma skin...